N-Ethylhexedrone was patented via the German pharmaceutical enterprise Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[one]Consequently a minimal quantity of sample is required for precise benefits, preserving the rest for proof or long run lab screening.